Science Explorer Back to mapMap
Discussion
Company · Emeryville · United States

Eureka Therapeutics (United States)

eurekatherapeutics.comROR OpenAlex
Research works
46
▼ 7% vs 2018-21
Citations
1.3k
28.1 per fractional work
Top-10% rate
12.5%
all institutions 10.0%
Open access
45%
world 40%
International
22%
world 18%
Eureka Therapeutics (United States)

Not ranked overall: Eureka Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Eureka Therapeutics (United States) work in?

In all years, 56% of research at Eureka Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (13%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 26 fractional works · 56.4% of its workMedicine: 25 fractional works · 54.2% of its workOncology: 14 fractional works · 31.0% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 8.6% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.4% of its workSurgery: 1 fractional works · 2.1% of its workNeurology: 1 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workPhysiology: 0 fractional works · 1.0% of its workHematology: 0 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 2.2% of its workGeneral Health Professions: 1 fractional works · 2.2% of its workLife Sciences: 16 fractional works · 35.7% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 22.5% of its workMolecular Biology: 7 fractional works · 16.0% of its workGenetics: 2 fractional works · 4.0% of its workBiophysics: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.7% of its workCancer Research: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 6 fractional works · 12.8% of its workImmunology: 6 fractional works · 12.5% of its workVirology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 7.6% of its workEngineering: 2 fractional works · 4.0% of its workBiomedical Engineering: 1 fractional works · 3.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.9% of its workEnvironmental Science: 1 fractional works · 2.6% of its workEcology: 0 fractional works · 1.1% of its workGlobal and Planetary Change: 0 fractional works · 0.8% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.4% of its workNature and Landscape Conservation: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKEurekaTherapeutics…46fractional works, all years
Life Sciences36%Physical Sciences8%Health Sciences56%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine2554.2%
    2. Health Professions12.2%
    1. Biochemistry, Genetics and Molecular Biology1022.5%
    2. Immunology and Microbiology612.8%
    3. Neuroscience00.2%
    4. Agricultural and Biological Sciences00.2%
    1. Engineering24.0%
    2. Environmental Science12.6%
    3. Computer Science00.6%
    4. Mathematics00.2%
    5. Chemistry00.2%
    1. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.60× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 14.38× its world share, 2 worksImmunology and Micro…Chemistry: 0.29× its world share, 0 worksChemistryEngineering: 0.23× its world share, 0 worksEngineeringEnvironmental Science: 0.29× its world share, 0 worksEnvironmental ScienceMedicine: 3.15× its world share, 9 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology14.38×2 works
  2. Biochemistry, Genetics and Molecular Biology3.60×3 works
  3. Medicine3.15×9 works
  4. Chemistry0.29×0 works
  5. Environmental Science0.29×0 works
  6. Engineering0.23×0 works
  7. Agricultural and Biological Sciences0.12×0 works

Who are the top researchers at Eureka Therapeutics (United States)?

Ranked on the quality score, Yiyang Xu, Jingyi Xiang and Lucas H. Horan lead among researchers whose main affiliation is Eureka Therapeutics (United States).

  1. 1 Yiyang Xu United States · #390,704 worldwide 1.2k citations · 19 works
  2. 2 Jingyi Xiang United States · #742,997 worldwide 1.6k citations · 44 works
  3. 3 Lucas H. Horan United States · #776,358 worldwide 1k citations · 24 works
  4. 4 Su Yan United States · #1,100,386 worldwide 1.6k citations · 21 works
  5. 5 Liu C United States · #1,268,183 worldwide 6.8k citations · 446 works
  6. 6 Shon Green United States · #1,445,848 worldwide 493 citations · 80 works
  7. 7 Long Li United States · #2,779,290 worldwide 510 citations · 18 works
  8. 8 Cheng Liu United States · #5,305,864 worldwide 154 citations · 38 works
All ranked researchers at Eureka Therapeutics (United States)

What are the most cited papers from Eureka Therapeutics (United States)?

The most cited paper from Eureka Therapeutics (United States) is "Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo" (Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al., 2018), with 852 citations. Next come "GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells" (395) and "Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer" (233).

Most cited papers
#PaperReleasedCitations
1 Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology Open access 13 Aug 2018 852
2 GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells Eric L. Smith et al. · Science Translational Medicine Open access 27 Mar 2019 395
3 Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer Hong Liu et al. · Clinical Cancer Research 17 Aug 2016 233
4 A membrane-associated MHC-I inhibitory axis for cancer immune evasion Xufeng Chen et al. · Cell Open access Aug 2023 209
5 Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody Tao Dao, Su Yan, Nicholas J. Veomett et al. · Science Translational Medicine Open access 13 Mar 2013 184
All 71 most cited papers, with filters and sorting

Which keywords describe research at Eureka Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Cancer Immunotherapy14▲ 214×3 topics
  2. Immunotherapy12▲ 41×7 topics
  3. Lymphoma11▲ 164×2 topics
  4. Tumor Regression11▲ 281×2 topics
  5. CAR T Cells11▲ 547×1 topic
  6. Chimeric Antigen Receptor11▲ 547×1 topic
  7. Glycosylation6▲ 58×3 topics
  8. Monoclonal Antibodies4▲ 69×3 topics
  9. Therapeutic Antibodies4▲ 69×2 topics
  10. Antibody Engineering4▲ 81×1 topic
  11. Fc Receptors4▲ 81×1 topic
  12. Immunity2▲ 16×3 topics
  13. Antigen Presentation2▲ 50×2 topics
  14. Innate Immunity2▲ 14×2 topics
  15. Dendritic Cells2▲ 42×1 topic
  16. Tumor Antigen2▲ 59×1 topic
  17. Cell Culture2▲ 41×2 topics
  18. Gene Therapy2▲ 17×4 topics
  19. Tumor Microenvironment2▲ 12×4 topics
  20. Cancer2▲ 2.9×11 topics
  21. Metabolism2▲ 6.2×5 topics
  22. Biopharmaceutical Production2▲ 46×2 topics
  23. Monoclonal Antibody2▲ 53×2 topics
  24. Inflammation2▲ 1.51×9 topics
  25. Mammalian Cells2▲ 91×1 topic
  26. Recombinant Protein2▲ 91×1 topic
  27. Nuclear Receptors2▲ 18×3 topics
  28. Kidney Organoids1▲ 88×1 topic
  29. Nephrogenesis1▲ 88×1 topic
  30. Prognostic Factors1▲ 6.5×5 topics
  31. AAV1▲ 40×1 topic
  32. Genomic Integration1▲ 25×2 topics
  33. Immune Checkpoint Blockade1▲ 49×1 topic
  34. PD-1 and PD-L11▲ 49×1 topic
  35. Viral Vectors1▲ 40×1 topic
  36. Autoimmunity1▲ 12×2 topics
  37. Macrophage1▲ 43×2 topics
  38. Collaborative Partnerships1▲ 105×1 topic
  39. Community Empowerment1▲ 6.8×1 topic

Which research topics does Eureka Therapeutics (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

CAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksNeonatal Respiratory Health Research: 0 fractional worksVirus-based gene therapy research: 0 fractional worksCystic Fibrosis Research Advances: 0 fractional worksCancer Cells and Metastasis: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingImmunologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 0 works
  6. 6 T-cell and B-cell Immunology Immunology 0 works
  7. 7 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  8. 8 Virus-based gene therapy research Genetics 0 works
  9. 9 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  10. 10 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 40% of research is openly available.

with international co-authors21.9%domestic only78.1%

World: 18% is written across borders.

How has Eureka Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 7% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eureka Therapeutics (United States) as a percentage of every work published that year, 0.000020% in 2024.

still counting0.00010%0.00020%Eureka Therapeutics (United States)0.000097% in 2025200020102020

Fractional works of Eureka Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Emeryville

All research institutions in Emeryville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eureka Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.